Inflammation, Aβ deposition, and neurofibrillary tangle formation as correlates of Alzheimer's disease neurodegeneration

Journal of Neuropathology and Experimental Neurology

Volumn 55, Issue 10, 1996, Pages 1083-1088

  Lue, Lih Fen ^a   Brachova, Libuse ^a   Civin, W Harold ^a   Rogers, Joseph ^a  

^a SUN HEALTH RESEARCH INSTITUTE   (United States)

Author keywords

Alzheimer's disease; Amyloid peptide; Inflammation; Membrane attack complex; Microglia; Neurofibrillary tangle; Synapse

Indexed keywords

AMYLOID BETA PROTEIN; COMPLEMENT MEMBRANE ATTACK COMPLEX; SYNAPTOPHYSIN;

AGED; ALZHEIMER DISEASE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ENTORHINAL CORTEX; FEMALE; HUMAN; HUMAN TISSUE; INFLAMMATION; MALE; MICROGLIA; NERVE DEGENERATION; NEUROFIBRILLARY TANGLE; PRIORITY JOURNAL; SENILE PLAQUE; SYNAPSE;

EID: 0029795517     PISSN: 00223069     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005072-199655100-00008     Document Type: Article

References (24)

1. Brachova L, Lue L-F, Byttner S, Civin WH, Schultz J, Tuohy J, Rogers J. Reduced complement activation in nondemented patients with excessive β-amyloid peptide deposition. (Abstract) Neurosci Abst 1992;19:833
2. Katzman R, Terry R, DeTeresa R, et al. Clinical, pathological, and neurochemical changes in dementia: A subgroup with preserved mental status and numerous neocortical plaques. Ann Neurol 1988;23:138-44
3. Terry RD, Masliah E, Salmon DP, et al. Physical basis of cognitive alterations in Alzheimer's disease: Synapse loss is the major correlate of cognitive impairment. Ann Neurol 1991;30:572-80
4. Crystal H, Dickson D, Fuld P, et al. Clinico-pathologic studies in dementia: Nondemented subjects with pathologically confirmed Alzheimer's disease. Neurol 1998;38:1682-87
5. Dickson DW, Crystal HA, Mattiace LA, et al. Identification of normal and pathological aging in prospectively studied nondemented elderly humans. Neurobiol Aging 1991;13:179-89
6. Arriagada PV, Marzloff K, Hyman BT. Distribution of Alzheimer-type pathologic changes in nondemented elderly individuals matches the pattern in Alzheimer's disease. Neurol 1992;42:1681-88
7. Markesbery WR. The diagnosis of Alzheimer's disease. Arch Pathol Lab Med 1993;117:129-31
8. Hyman BT, Tanzi RE, Marzloff KM, Barbour R, Schenk D. Kunitz protease inhibitor containing amyloid precursor protein immunoreactivity in Alzheimer's disease. J Neuropathol Exp Neurol 1992;51:76-83
9. Webster S, O'Barr S, Rogers J. Enhanced aggregation and β structure of amyloid β peptide after co-incubation with C1q. J Neurosci Res 1994;39:448-56
10. Kuby J. The complement system: Biological consequences of complement activation. Immunology. WH Freeman and Company: New York, 1992:349-56
11. Rogers J, Lue L-F, Brachova L, Webster S, Schultz J. Inflammation as a response and a cause of Alzheimer's pathophysiology. Dementia (Japan) 1995;9:133-38
12. Rogers J, Cooper NR, Schultz J, et al. Complement activation by β-amyloid in Alzheimer's disease. Proc Nat Acad Sci USA 1992;89:10016-20
13. Perlmutter LS, Scott SA, Barron E, Chui HC. MHC Class II-positive microglia in human brain: Association with Alzheimer lesions. J Neurosci Res 1992;33:549-58
14. Dickson DW, Rogers J. Neuroimmunology of Alzheimer's disease. Neurobiol Aging 1992;15:793-98
15. Styren SD, Civin WH, Rogers J. Molecular, cellular, and pathologic characterization of HLA-DR immunoreactivity in normal elderly and Alzheimer's disease brain. Exp Neurol 1990;110:93-104
16. Luber-Narod J, Rogers J. Immune system associated antigens expressed by cells of the human central nervous system. Neurosci Lett 1988;94:17-22
17. Brachova L, Lue L-F, Clark TD, Walker DG, Lorton D, Rogers J. Constitutive and amyloid β peptide stimulated expression of inflammatory mediators by cultured microglia from Alzheimer's disease and nondemented elderly patients. (Abstract) Neurosci Abst 1995;21:740
18. Rogers J, Webster S, Lue L-F, et al. Inflammation and Alzheimer's disease pathogenesis. Neurobiol Aging (in press)
19. Van Hoesen GW, Solodkin A. Some modular features of temporal cortex in humans as revealed by pathological changes in Alzheimer's disease. Cerebral Cortex 1993;3:465-75
20. Hyman BT, Van Hoesen GW, Damasio AR, Barnes CL. Alzheimer's disease: Cell-specific pathology isolates the hippocampal formation. Science 1984;225:1168-70
21. Van Hoesen GW, Hyman BT, Demasio AR. Entorhinal cortex pathology in Alzheimer's disease. Hippocampus 1991;1:1-8
22. Caputo CB. A possible relationship between the plaques and tangles of Alzheimer's disease. Int Acad Biomed Drug Res 1994;7:191-96
23. DeLacoste MC, White CL. The role of cortical connectivity in Alzheimer's disease pathogenesis: A review and model system. Neurobiol Aging 1993;14:1-16
24. Araujo DM, Cotman CW. β-amyloid stimulates glial cells in vitro to produce growth factors that accumulate in senile plaques in Alzheimer's disease. Brain Res 1992;569:141-45